
Episode #6
Scaling a Biotech Business: Lessons on Pivoting & Growth from Affinity Immuno
<p>Amir describes a non-linear path into science, switching from social sciences after rediscovering biology and finding organic chemistry intuitive and creative. She explains her PhD work at the University of Calgary in carbohydrate chemistry, synthesizing tumor-associated carbohydrates to support vaccine and detection research. </p><p>Amir outlines how Affinity Immuno started with off-the-shelf ELISA kits, grew within PEI’s expanding biotech ecosystem, and pivoted during COVID-19 to pandemic research tools, rapidly scaling and engaging globally before facing a post-COVID downturn. She details the company’s customer-driven expansion into custom polyclonal chicken antibody production and method development/validation, while preferring organ...

